Equities Research Analysts’ upgrades for Thursday, May 23rd:
Ascendis Pharma A/S (NASDAQ:ASND) was upgraded by analysts at StockNews.com from a sell rating to a hold rating.
Chubb (NYSE:CB) was upgraded by analysts at Bank of America Co. from an underperform rating to a neutral rating. The firm currently has $266.00 price target on the stock, up from their previous price target of $244.00.
CI&T (NYSE:CINT) was upgraded by analysts at Canaccord Genuity Group Inc. from a hold rating to a buy rating. Canaccord Genuity Group Inc. currently has $6.00 target price on the stock, up from their previous target price of $5.00.
Americold Realty Trust (NYSE:COLD) was upgraded by analysts at Scotiabank from a sector perform rating to a sector outperform rating. They currently have $30.00 target price on the stock, up from their previous target price of $27.00.
Cousins Properties (NYSE:CUZ) was upgraded by analysts at StockNews.com from a sell rating to a hold rating.
Eastman Chemical (NYSE:EMN) was upgraded by analysts at UBS Group AG from a neutral rating to a buy rating. The firm currently has $128.00 target price on the stock, up from their previous target price of $106.00.
FB Financial (NYSE:FBK) was upgraded by analysts at Stephens from an equal weight rating to an overweight rating. The firm currently has $45.00 target price on the stock, up from their previous target price of $39.00.
Freshpet (NASDAQ:FRPT) was upgraded by analysts at Redburn Atlantic from a neutral rating to a buy rating. The firm currently has $168.00 target price on the stock.
GoodRx (NASDAQ:GDRX) was upgraded by analysts at Royal Bank of Canada from a sector perform rating to an outperform rating. Royal Bank of Canada currently has $10.00 price target on the stock, up from their previous price target of $8.00.
Hasbro (NASDAQ:HAS) was upgraded by analysts at JPMorgan Chase & Co. from a neutral rating to an overweight rating. They currently have $74.00 price target on the stock, up from their previous price target of $61.00.
Hovnanian Enterprises (NYSE:HOV) was upgraded by analysts at Zelman & Associates from an underperform rating to a neutral rating. They currently have $155.00 price target on the stock.
HighPeak Energy (NASDAQ:HPK) was upgraded by analysts at Truist Financial Co. from a sell rating to a hold rating. They currently have $13.00 price target on the stock, up from their previous price target of $10.00.
International Paper (NYSE:IP) was upgraded by analysts at Jefferies Financial Group Inc. from a hold rating to a buy rating. The firm currently has $57.00 target price on the stock, up from their previous target price of $38.00.
NICE (NASDAQ:NICE) was upgraded by analysts at StockNews.com from a hold rating to a buy rating.
Norfolk Southern (NYSE:NSC) was upgraded by analysts at Royal Bank of Canada from a sector perform rating to an outperform rating. They currently have $270.00 target price on the stock.
RADCOM (NASDAQ:RDCM) was upgraded by analysts at StockNews.com from a buy rating to a strong-buy rating.
Take-Two Interactive Software (NASDAQ:TTWO) was upgraded by analysts at Bank of America Co. from a neutral rating to a buy rating. Bank of America Co. currently has $185.00 target price on the stock, up from their previous target price of $160.00.
Unilever (NYSE:UL) was upgraded by analysts at JPMorgan Chase & Co. from an underweight rating to an overweight rating.
Wynn Resorts (NASDAQ:WYNN) was upgraded by analysts at Argus from a hold rating to a buy rating. Argus currently has $110.00 target price on the stock.
XPeng (NYSE:XPEV) was upgraded by analysts at Daiwa Capital Markets from a neutral rating to a buy rating. The firm currently has $11.00 price target on the stock.
22nd Century Group (NASDAQ:XXII) was upgraded by analysts at StockNews.com to a sell rating.
YPF Sociedad AnĂ³nima (NYSE:YPF) was upgraded by analysts at Bank of America Co. from an underperform rating to a neutral rating.
Receive News & Ratings for Ascendis Pharma A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascendis Pharma A/S and related companies with MarketBeat.com's FREE daily email newsletter.